StonvexLoading…
StonvexStonvexStonvexCore line items from PNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.18B | $4.08B | $4.10B | $4.12B |
Operating Income | $857.50M | $803.80M | $739.20M | $595.30M |
Net Income | $653.80M | $625.40M | $622.70M | $480.90M |
EPS (Diluted) | $3.96 | $3.74 | $3.75 | $2.90 |
Total Assets | $6.87B | $6.45B | $6.56B | $6.45B |
Total Liabilities | $3.00B | $2.88B | $3.35B | $3.74B |
Cash & Equivalents | $101.60M | $118.70M | $170.30M | $108.90M |
Free Cash Flow OCF − CapEx | $746.00M | $692.30M | $543.20M | $278.10M |
Shares Outstanding | 165.50M | 167.10M | 166.30M | 165.60M |